Medication Access and Training Expansion Improvement Act or the MATE Improvement Act This bill expands the types of organizations that may provide required training for practitioners registering with the Drug Enforcement Administration (DEA) to dispense (i.e., prescribe or administer) certain controlled substances. Current law requires health care practitioners to register with the DEA and complete a one-time training on substance use disorders from specified entities in order to dispense schedule II-V controlled substances. Practitioners who graduated within the last five years from specified types of schools and whose curriculum included similar training on substance use disorders are exempt from having to receive this additional training. The bill adds several organizations (e.g., the American Academy of Family Physicians) to the list of entities that may provide the required one-time training for physicians or other practitioners. It also expands the types of practitioners who are exempt from this training requirement to include those who graduated from schools of podiatric medicine or schools of pharmacy within the last five years and received similar training as part of their curriculums. The bill applies retroactively, taking effect as if enacted on December 29, 2022.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill introduced
Lobbying filed by ORSTED NORTH AMERICA INC
Lobbying filed by BIOTECHNOLOGY INNOVATION ORGANIZATION
Lobbying filed by ORSTED NORTH AMERICA INC
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BIOTECHNOLOGY INNOVATION ORGANIZATION | $1.8M | Jul 21, 2025 | 2025Q2 | MMMAGRANI |
| ORSTED NORTH AMERICA, INC. | ORSTED NORTH AMERICA INC | $480.0K | Jul 21, 2025 | 2025Q2 | ENG |
| ORSTED NORTH AMERICA, INC. | ORSTED NORTH AMERICA INC |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.
| $300.0K |
| Apr 21, 2025 |
| 2025Q1 |
ENG |